Published in Lab Business Week, February 4th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Roche.
The drug has also been granted Fast Track designation by the U.S. Food and Drug Administration, a program designed to facilitate the development and to expedite the review of new drugs with the potential to help treat serious or life-threatening conditions.
R1626, which has been shown to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.